Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225637
Filing Date
2012-05-10
Accepted
2012-05-10 16:24:05
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d348497d10q.htm 10-Q 623649
2 FORM OF RETENTION BONUS LETTER AGREEMENT d348497dex106.htm EX-10.6 8326
3 FORM OF ISSUANCE OF AN OFFICER RSU RETENTION GRANT LETTER AGREEMENT d348497dex107.htm EX-10.7 8301
4 2012 CASH BONUS PLAN d348497dex108.htm EX-10.8 23354
5 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) d348497dex311.htm EX-31.1 6988
6 CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) d348497dex312.htm EX-31.2 7272
7 CERTIFICATIONS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) d348497dex321.htm EX-32.1 4670
  Complete submission text file 0001193125-12-225637.txt   2180543

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alxa-20120331.xml EX-101.INS 250260
9 XBRL TAXONOMY EXTENSION SCHEMA alxa-20120331.xsd EX-101.SCH 12313
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20120331_cal.xml EX-101.CAL 39800
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20120331_lab.xml EX-101.LAB 106620
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20120331_pre.xml EX-101.PRE 68280
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 12830613
SIC: 2834 Pharmaceutical Preparations